Schedule 13G ownership disclosure

Corvus Pharmaceuticals Inc

Security class unavailable · CUSIP: 221015100

Event date: 2021-09-22

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
5,081,077
Percent of class
12.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000935836-21-000536
Form type
SC 13G/A
Filer
Corvus Pharmaceuticals, Inc.
CIK
CIK 1626971
Filed
Sep 23, 2021
Reporting period
Sep 22, 2021
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub